Wacker and Expression Manufacturing want to offer clients with an end-to-end, optimized solution for viral vector development and production.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

US biotech Lexeo Therapeutics has secured $80 million from a private placement, giving the company enough capital to push ...